We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
-0.43%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$116M
AUM Growth
-$269K
Cap. Flow
+$263K
Cap. Flow %
0.23%
Top 10 Hldgs %
19.61%
Holding
199
New
30
Increased
53
Reduced
57
Closed
37

Top Buys

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$1.14M
2
SYY icon
Sysco
SYY
+$1.14M
3
BNY
Bank of New York Mellon
BNY
+$1.11M
4
KMB icon
Kimberly-Clark
KMB
+$1.08M
5
AMGN icon
Amgen
AMGN
+$1.01M

Top Sells

Rank Stock Value
1
CNI icon
Canadian National Railway
CNI
+$1.4M
2
TKR icon
Timken Company
TKR
+$1.16M
3
PRXL
Parexel International Corp
PRXL
+$1.1M
4
LCI
Lannett Company, Inc.
LCI
+$949K
5
EL icon
Estee Lauder
EL
+$920K

Sector Composition

Rank Sector Weight
1 Healthcare 19.04%
2 Industrials 18.96%
3 Technology 14.93%
4 Consumer Staples 12.75%
5 Financials 12.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HON icon
101
Honeywell
HON
$64.5B
$452K 0.39%
4,827
+42
+0.9% +$3.84K
SAVE
102
DELISTED
Spirit Airlines, Inc.
SAVE
$449K 0.39%
+5,800
New +$445K
WPC icon
103
W.P. Carey
WPC
$15.6B
$441K 0.38%
6,620
– –
CNBKA
104
DELISTED
Century Bancorp Inc/Mass
CNBKA
$433K 0.37%
10,895
-150
-1% -$5.91K
THRM icon
105
Gentherm
THRM
$1.17B
$429K 0.37%
8,495
-2,850
-25% -$121K
LLTC
106
DELISTED
Linear Technology Corp
LLTC
$424K 0.36%
9,050
-275
-3% -$12.9K
MDLZ icon
107
Mondelez International
MDLZ
$79.3B
$423K 0.36%
11,723
+73
+0.6% +$2.64K
BMR
108
DELISTED
BIOMED REALTY TRUST INC
BMR
$417K 0.36%
18,400
+500
+3% +$11.5K
SRCL
109
DELISTED
Stericycle Inc
SRCL
$407K 0.35%
+2,900
New +$392K
FLR icon
110
Fluor
FLR
$7.23B
$400K 0.34%
7,000
-4,750
-40% -$270K
TROW icon
111
T. Rowe Price
TROW
$22.2B
$399K 0.34%
4,925
-550
-10% -$45.3K
KMI icon
112
Kinder Morgan
KMI
$68.5B
$395K 0.34%
9,394
– –
FULT icon
113
Fulton Financial
FULT
$4.53B
$392K 0.34%
31,800
-600
-2% -$7.19K
BNS icon
114
Scotiabank
BNS
$114B
$391K 0.34%
8,215
-10,170
-55% -$497K
UAA icon
115
Under Armour
UAA
$2.13B
$388K 0.33%
9,600
-600
-6% -$22.1K
STJ
116
DELISTED
St Jude Medical
STJ
$387K 0.33%
+5,925
New +$394K
WST icon
117
West Pharmaceutical
WST
$25.7B
$374K 0.32%
6,206
– –
AERI
118
DELISTED
Aerie Pharmaceuticals
AERI
$360K 0.31%
11,500
-4,725
-29% -$137K
ESRX
119
DELISTED
Express Scripts Holding Company
ESRX
$360K 0.31%
+4,150
New +$348K
DISCK
120
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$358K 0.31%
12,150
– –
AA icon
121
Alcoa
AA
$12.3B
$337K 0.29%
10,861
-3,663
-25% -$132K
ADBE icon
122
Adobe
ADBE
$102B
$336K 0.29%
4,550
+1,275
+39% +$95.1K
NEE icon
123
NextEra Energy
NEE
$169B
$328K 0.28%
12,600
– –
SNY icon
124
Sanofi
SNY
$102B
$326K 0.28%
6,600
– –
ALGN icon
125
Align Technology
ALGN
$10.4B
$325K 0.28%
+6,050
New +$345K
3 4
5
6 7

Similar funds

GFP
Guardian Financial Partners Orange, California $257M AUM 19.03% 1-Year Est. Return
UI
Untitled Investments New York $257M AUM 15.31% 1-Year Est. Return
HWA
HMV Wealth Advisors Shreveport, Louisiana $257M AUM 26.62% 1-Year Est. Return
LGW
Leslie Global Wealth Itasca, Illinois $257M AUM 23.12% 1-Year Est. Return
TCG
Transcendent Capital Group Edmond, Oklahoma $257M AUM 25.68% 1-Year Est. Return
6F
626 Financial Portage, Michigan $257M AUM 22.23% 1-Year Est. Return
MCP
Miller Capital Partners Troy, Michigan $257M AUM
BWM
Birchcreek Wealth Management Miami Township, Ohio $257M AUM 34.72% 1-Year Est. Return

New England Research & Management's Q1 2015 Portfolio in Review

As of Q1 2015, New England Research & Management held 199 positions worth $116M, down 0.23% from $117M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

New England Research & Management's Q1 2015 filing shows 30 new, 53 increased, 57 reduced and 37 closed positions. Its largest new stake was Bank of New York Mellon: 28,400 shares worth $1.14M. The largest sale was Canadian National Railway, an estimated $1.4M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Industrials and Technology.

  • New England Research & Management's largest Q1 2015 buy was Bank of New York Mellon: 28,400 shares worth $1.14M.
  • New England Research & Management added most to KLA in Q1 2015, an estimated $1.14M increase.
  • New England Research & Management's biggest Q1 2015 reduction was Parexel International Corp, cutting an estimated $1.1M.
  • New England Research & Management fully exited Canadian National Railway in Q1 2015, selling an estimated $1.4M.
  • New England Research & Management's ten largest holdings make up 20% of its $116M portfolio in Q1 2015.
  • New England Research & Management opened 30 new positions and closed 37 in Q1 2015.
  • New England Research & Management's portfolio value fell 0.23% quarter-over-quarter to $116M.

Based on New England Research & Management's 13F filing for Q1 2015, filed 6 Apr 2015.